# Mechanisms of Basal Cell Dysfunction in Chemical-induced Bronchiolitis Obliterans

> **NIH NIH K08** · UNIVERSITY OF ROCHESTER · 2022 · $234,038

## Abstract

PROJECT SUMMARY
This Mentored Clinical Scientist Research Career Development application will support Dr. Matthew McGraw in
his transition to independence as a clinician scientist studying the mechanisms of airway basal cell dysfunction
in chemical-induced bronchiolitis obliterans (BO). BO is a devastating fibrotic airways disease, most commonly
seen after organ transplant. However, BO is becoming more frequently associated with inhalation exposures to
certain viruses or chemicals. One of the most well-known chemicals associated with inhalation-induced BO is
diacetyl (DA; 2,3-butanedione), a highly reactive diketone found in foods, coffee and e-cigarettes. Despite DA’s
common use as a flavoring additive, the mechanisms of DA-induced BO remain poorly understood. Central to
BO development is injury to the airway epithelium. When injured, the airway relies on epithelial progenitor cells
for proper repair. The objective of this application is to better understand the functional role of airway basal cells,
the primary progenitor cell of the human airway, in chemical-induced BO. Two preclinical models of chemical-
induced BO were developed for this application. First, rats exposed consecutively to DA vapors developed
persistent hypoxemia, reduced weight gain, and histologic evidence of BO. Poly-ubiquitinated proteins
accumulated in rat airways after DA exposures not seen in air controls. Second, in human airway epithelial cells
exposed to DA vapors, poly-ubiquitinated proteins accumulated and co-localized primarily with airway basal
cells. With repetitive DA exposures, the accumulation of polyubiquitinated proteins resulted in proteotoxicity of
airway basal cells. Our central hypothesis is repetitive DA vapor exposures results in abundant protein damage,
leading to proteotoxicity of airway basal cells, impairing airway epithelial repair and promoting BO development.
Aim I of this proposal will determine how abundant protein damage in airway basal cells impairs epithelial repair
and promotes BO development using both models of repetitive DA vapor exposure. Aim II will determine the role
of the ubiquitin proteasome system in airway basal cell toxicity and BO development. Aim III will compare the
efficacy of multiple ubiquitin proteasome pathway drug targets in preventing basal cell toxicity and BO
development. Dr. McGraw has assembled a mentoring team of experts in the fields of airway epithelial biology
(T Mariani, PhD; primary), inhalation toxicology (JN Finkelstein, PhD; I Rahman, PhD), and proteomics (WJ Qian,
PhD) for critically examining the role of airway basal cells in chemical-induced BO. Mentoring in airway stem cell
biology and proteomics, as described in this proposal, will facilitate Dr. McGraw’s transition to independence. At
K08 completion, the data generated from this application will significantly advance our understanding of airway
basal cell function following inhalation exposures and have a broader impact on neighboring research field...

## Key facts

- **NIH application ID:** 10523626
- **Project number:** 1K08ES033290-01A1
- **Recipient organization:** UNIVERSITY OF ROCHESTER
- **Principal Investigator:** Matthew Daniel McGraw
- **Activity code:** K08 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $234,038
- **Award type:** 1
- **Project period:** 2022-09-01 → 2026-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10523626

## Citation

> US National Institutes of Health, RePORTER application 10523626, Mechanisms of Basal Cell Dysfunction in Chemical-induced Bronchiolitis Obliterans (1K08ES033290-01A1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10523626. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*